These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 17220790)

  • 1. Mycophenolate mofetil and C-reactive protein in renal transplant recipients.
    Wong BM; Huang M; Zaltzman JS; Prasad GV
    Transplantation; 2007 Jan; 83(1):48-53. PubMed ID: 17220790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
    Flechner SM; Zhou L; Derweesh I; Mastroianni B; Savas K; Goldfarb D; Modlin CS; Krishnamurthi V; Novick A
    Transplantation; 2003 Dec; 76(12):1729-34. PubMed ID: 14688524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S; Daswani A; Takemoto SK
    Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of transplanted kidney function in patients on two different doses of mycophenolate mofetil.
    Khosroshahi HT; Nahali A; Gojazadeh M; Shoja MM
    Transplant Proc; 2006 Sep; 38(7):2035-7. PubMed ID: 16979991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients.
    van Ree RM; de Vries AP; Oterdoom LH; The TH; Gansevoort RT; Homan van der Heide JJ; van Son WJ; Ploeg RJ; de Jong PE; Gans RO; Bakker SJ
    Nephrol Dial Transplant; 2005 Nov; 20(11):2524-31. PubMed ID: 16115856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum C-reactive protein surge in renal transplant recipients: link with allograft survival.
    Ozdemir NF; Elsurer R; Ibis A; Arat Z; Haberal M
    Transplant Proc; 2007 May; 39(4):934-7. PubMed ID: 17524855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.
    Budde K; Glander P; Diekmann F; Dragun D; Waiser J; Fritsche L; Neumayer HH
    Transplant Proc; 2004 Mar; 36(2 Suppl):524S-527S. PubMed ID: 15041401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression.
    Tsai MK; Hu RH; Lee CJ; Lee PH
    J Formos Med Assoc; 2002 Sep; 101(9):616-21. PubMed ID: 12645188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in renal transplant recipients following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium.
    Cofan F; Rosich E; Arias M; Torregrosa V; Oppenheimer F; Campistol JM
    Transplant Proc; 2007 Sep; 39(7):2179-81. PubMed ID: 17889130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does mycophenolate mofetil increase the incidence of infections in stable renal transplant recipients initially treated with a two-drug regimen?
    Chen Y; Chu SH; Wei TY; Yen TH; Chiang YJ; Wu CT; Chen HW
    Transplant Proc; 2004 Sep; 36(7):2122-3. PubMed ID: 15518769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion to combined therapy with sirolimus and mycophenolate mofetil improved renal function in stable renal transplant recipients.
    Tsai MK; Lee CY; Hu RH; Lee PH
    J Formos Med Assoc; 2007 May; 106(5):372-9. PubMed ID: 17561472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.
    Lederer SR; Friedrich N; Banas B; Welser G; Albert ED; Sitter T
    Clin Transplant; 2005 Apr; 19(2):168-74. PubMed ID: 15740551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients.
    Khosroshahi HT; Asghari A; Estakhr R; Baiaz B; Ardalan MR; Shoja MM
    Transplant Proc; 2006 Sep; 38(7):2077-9. PubMed ID: 16980004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte sodium lithium countertransport in renal transplant recipients with mycophenolate mofetil and low-dose cyclosporine.
    Vareesangthip K; Hanlakorn P; Suwannaton L; Larpkitkachorn R; Chuawattana D; Pidetcha P; Ong-Aj-Yooth L
    Transplant Proc; 2004 Dec; 36(10):3032-5. PubMed ID: 15686688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.
    Wong W; Tolkoff-Rubin N; Delmonico FL; Cardarelli F; Saidman SL; Farrell ML; Shih V; Winkelmayer WC; Cosimi AB; Pascual M
    Clin Transplant; 2004 Aug; 18(4):341-8. PubMed ID: 15233807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
    Ducloux D; Motte G; Billerey C; Bresson-Vautrin C; Vautrin P; Rebibou JM; Saint-Hillier Y; Chalopin JM
    Transpl Int; 2002 Sep; 15(8):387-92. PubMed ID: 12221456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation.
    Neff RT; Hurst FP; Falta EM; Bohen EM; Lentine KL; Dharnidharka VR; Agodoa LY; Jindal RM; Yuan CM; Abbott KC
    Transplantation; 2008 Nov; 86(10):1474-8. PubMed ID: 19034021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.